Karen Bernstein's most recent trade in Ovid Therapeutics Inc was a trade of 45,000 Stock Option (right to buy) done . Disclosure was reported to the exchange on Feb. 20, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Ovid Therapeutics Inc | Karen Bernstein | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 45,000 | 45,000 | - | - | Stock Option (right to buy) | |
| Ovid Therapeutics Inc | Karen Bernstein | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Dec 2024 | 90,000 | 90,000 | - | - | Stock Option (Right to Buy) | |
| Ovid Therapeutics Inc | Bernstein Karen | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2024 | 30,000 | 30,000 | - | - | Stock Option (Right to Buy) | |
| Ovid Therapeutics Inc | Karen Bernstein | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2023 | 15,000 | 15,000 | - | - | Stock Option (Right to Buy) | |
| Ovid Therapeutics Inc | Karen Bernstein | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Apr 2022 | 69,424 | 69,424 | - | - | Stock Option (right to buy) | |
| Ovid Therapeutics Inc | Karen Bernstein | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 May 2021 | 1,750 | 1,750 | - | - | Stock Option (Right to Buy) |